- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 24 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 4 residues within 4Å:- Chain A: E.92, N.93
- Chain B: G.16, S.17
No protein-ligand interaction detected (PLIP)NAG-NAG.3: 3 residues within 4Å:- Chain A: N.135, C.136, T.137
No protein-ligand interaction detected (PLIP)NAG-NAG.4: 2 residues within 4Å:- Chain A: N.157, K.166
No protein-ligand interaction detected (PLIP)NAG-NAG.5: 5 residues within 4Å:- Chain A: F.229, N.230, G.231, T.232, G.233
No protein-ligand interaction detected (PLIP)NAG-NAG.6: 5 residues within 4Å:- Chain A: E.88, V.90, N.225, N.237, S.239
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:E.88, A:V.90
NAG-NAG.8: 6 residues within 4Å:- Chain A: N.291, N.327, I.328, S.329, T.394, R.425
No protein-ligand interaction detected (PLIP)NAG-NAG.13: 4 residues within 4Å:- Chain A: V.179, P.180, R.188, N.193
No protein-ligand interaction detected (PLIP)NAG-NAG.14: 3 residues within 4Å:- Chain A: N.272, T.274, N.275
No protein-ligand interaction detected (PLIP)NAG-NAG.16: 4 residues within 4Å:- Chain E: E.92, N.93
- Chain F: G.16, S.17
No protein-ligand interaction detected (PLIP)NAG-NAG.17: 3 residues within 4Å:- Chain E: N.135, C.136, T.137
No protein-ligand interaction detected (PLIP)NAG-NAG.18: 2 residues within 4Å:- Chain E: N.157, K.166
No protein-ligand interaction detected (PLIP)NAG-NAG.19: 4 residues within 4Å:- Chain E: F.229, N.230, T.232, G.233
No protein-ligand interaction detected (PLIP)NAG-NAG.20: 5 residues within 4Å:- Chain E: E.88, V.90, N.225, N.237, S.239
2 PLIP interactions:2 interactions with chain E- Hydrophobic interactions: E:E.88, E:V.90
NAG-NAG.22: 4 residues within 4Å:- Chain E: N.291, N.327, S.329, T.394
No protein-ligand interaction detected (PLIP)NAG-NAG.27: 3 residues within 4Å:- Chain E: V.179, R.188, N.193
No protein-ligand interaction detected (PLIP)NAG-NAG.28: 3 residues within 4Å:- Chain E: N.272, T.274, N.275
No protein-ligand interaction detected (PLIP)NAG-NAG.30: 4 residues within 4Å:- Chain I: E.92, N.93
- Chain J: G.16, S.17
No protein-ligand interaction detected (PLIP)NAG-NAG.31: 3 residues within 4Å:- Chain I: N.135, C.136, T.137
No protein-ligand interaction detected (PLIP)NAG-NAG.32: 2 residues within 4Å:- Chain I: N.157, K.166
No protein-ligand interaction detected (PLIP)NAG-NAG.33: 4 residues within 4Å:- Chain I: F.229, N.230, T.232, G.233
No protein-ligand interaction detected (PLIP)NAG-NAG.34: 5 residues within 4Å:- Chain I: E.88, V.90, N.225, N.237, S.239
2 PLIP interactions:2 interactions with chain I- Hydrophobic interactions: I:E.88, I:V.90
NAG-NAG.36: 4 residues within 4Å:- Chain I: N.291, N.327, S.329, T.394
No protein-ligand interaction detected (PLIP)NAG-NAG.41: 3 residues within 4Å:- Chain I: V.179, R.188, N.193
No protein-ligand interaction detected (PLIP)NAG-NAG.42: 3 residues within 4Å:- Chain I: N.272, T.274, N.275
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN.7: 11 residues within 4Å:- Chain A: K.70, E.207, V.250, L.257, N.258, N.370, G.372, E.421, T.427, S.428
- Ligands: NAG-NAG-BMA.12
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:G.372, A:T.427
NAG-NAG-BMA-MAN-MAN-MAN-MAN.21: 11 residues within 4Å:- Chain E: K.70, E.207, V.250, L.257, N.258, N.370, G.372, E.421, T.427, S.428
- Ligands: NAG-NAG-BMA.26
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:G.372, E:T.427
NAG-NAG-BMA-MAN-MAN-MAN-MAN.35: 11 residues within 4Å:- Chain I: K.70, E.207, V.250, L.257, N.258, N.370, G.372, E.421, T.427, S.428
- Ligands: NAG-NAG-BMA.40
2 PLIP interactions:2 interactions with chain I- Hydrogen bonds: I:G.372, I:T.427
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.9: 3 residues within 4Å:- Chain A: N.297, I.318, K.423
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.23: 3 residues within 4Å:- Chain E: N.297, I.318, K.423
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.37: 3 residues within 4Å:- Chain I: N.297, I.318, K.423
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.10: 18 residues within 4Å:- Chain A: N.291, T.293, H.325, N.327, T.396, R.425
- Chain C: R.103, I.104, G.106, V.107, V.108
- Chain D: S.24, N.44, N.45, N.46, P.60, G.61, S.62
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:V.108
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.24: 16 residues within 4Å:- Chain E: T.293, H.325, N.327, T.396
- Chain G: R.103, I.104, G.106, V.107, V.108
- Chain H: S.24, N.44, N.45, N.46, P.60, G.61, S.62
1 PLIP interactions:1 interactions with chain G- Hydrogen bonds: G:V.108
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN.38: 15 residues within 4Å:- Chain I: T.293, H.325, N.327, T.396
- Chain K: R.103, I.104, G.106, V.107, V.108
- Chain L: N.44, N.45, N.46, P.60, G.61, S.62
1 PLIP interactions:1 interactions with chain K- Hydrogen bonds: K:V.108
- 6 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.11: 5 residues within 4Å:- Chain A: T.365, T.366, N.379, S.381, R.400
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.12: 4 residues within 4Å:- Chain A: S.287, T.427, N.429
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.7
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.25: 5 residues within 4Å:- Chain E: T.365, T.366, N.379, S.381, R.400
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.26: 4 residues within 4Å:- Chain E: S.287, T.427, N.429
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.21
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.39: 5 residues within 4Å:- Chain I: T.365, T.366, N.379, S.381, R.400
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.40: 5 residues within 4Å:- Chain I: S.287, T.427, S.428, N.429
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN.35
No protein-ligand interaction detected (PLIP)- 9 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.43: 4 residues within 4Å:- Chain A: E.264, E.265, N.285, Q.339
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:E.265
- Hydrogen bonds: A:E.264
NAG.44: 1 residues within 4Å:- Chain A: N.385
No protein-ligand interaction detected (PLIP)NAG.45: 3 residues within 4Å:- Chain B: P.98, W.99, N.100
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.100
NAG.46: 4 residues within 4Å:- Chain E: E.264, E.265, N.285, Q.339
2 PLIP interactions:2 interactions with chain E- Hydrophobic interactions: E:E.265
- Hydrogen bonds: E:E.264
NAG.47: 1 residues within 4Å:- Chain E: N.385
No protein-ligand interaction detected (PLIP)NAG.48: 4 residues within 4Å:- Chain F: P.98, W.99, N.100, W.103
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:N.100
NAG.49: 4 residues within 4Å:- Chain I: E.264, E.265, N.285, Q.339
2 PLIP interactions:2 interactions with chain I- Hydrophobic interactions: I:E.265
- Hydrogen bonds: I:E.264
NAG.50: 1 residues within 4Å:- Chain I: N.385
No protein-ligand interaction detected (PLIP)NAG.51: 4 residues within 4Å:- Chain J: P.98, W.99, N.100, W.103
1 PLIP interactions:1 interactions with chain J- Hydrogen bonds: J:N.100
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Martin, G.M. et al., Profound structural conservation of chemically cross-linked HIV-1 envelope glycoprotein experimental vaccine antigens. Npj Vaccines (2023)
- Release Date
- 2022-03-09
- Peptides
- HIV-1 Env glycoprotein gp120: AEI
HIV-1 Env glycoprotein gp41: BFJ
PGT122 Fab heavy chain: CGK
PGT122 Fab light chain: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
CI
EB
BF
DJ
FC
HG
NK
PD
LH
ML
O
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 24 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 9 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Martin, G.M. et al., Profound structural conservation of chemically cross-linked HIV-1 envelope glycoprotein experimental vaccine antigens. Npj Vaccines (2023)
- Release Date
- 2022-03-09
- Peptides
- HIV-1 Env glycoprotein gp120: AEI
HIV-1 Env glycoprotein gp41: BFJ
PGT122 Fab heavy chain: CGK
PGT122 Fab light chain: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
CI
EB
BF
DJ
FC
HG
NK
PD
LH
ML
O